• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

COVID-19 vaccination in peritoneal dialysis patients
ConclusionsThe COVID-19 vaccine was well-tolerated by most PD patients, but few experienced non-severe adverse effects. All PD patients should be vaccinated against SAR-COV-2 infection.
Source: International Urology and Nephrology - February 25, 2023 Category: Urology & Nephrology Source Type: research

Coronavirus Vaccinations In Massachusetts: New Groups Of Phase 1 Health Care Workers Now Eligible
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"5222089","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientId"...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 22, 2021 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Syndicated CBSN Boston Syndicated Local Coronavirus Coronavirus Vaccine Source Type: news

All Your Coronavirus Questions, Answered
One of the worst symptoms of any plague is uncertainty—who it will strike, when it will end, why it began. Merely understanding a pandemic does not stop it, but an informed public can help curb its impact and slow its spread. It can also provide a certain ease of mind in a decidedly uneasy time. Here are some of the most frequently asked questions about the COVID-19 pandemic from TIME’s readers, along with the best and most current answers science can provide. A note about our sourcing: While there are many, many studies underway investigating COVID-19 and SARS-CoV-19, the novel coronavirus that causes the illn...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized COVID-19 Explainer Source Type: news

Production of Recombinant Protein of Salsola Kali (Sal k1) Pollen Allergen in Lactococcus Lactis.
This study demonstrated that L. lactis may be used as a promising live delivery system for recombinant Sal k1 protein without altering its immunoreactivity; however, its efficacy in the context of the immune system is suggested to be pursued in future studies. PMID: 29757586 [PubMed - in process]
Source: Iranian Journal of Allergy, Asthma and Immunology - April 1, 2018 Category: Allergy & Immunology Authors: Ghasemi Z, Varasteh AR, Moghadam M, Sedghi F, Jabbariazad F, Sankian M Tags: Iran J Allergy Asthma Immunol Source Type: research

Hepatitis B vaccine non-responders: possible mechanisms and solutions
Hepatitis B (HBV) is a viral illness that chronically infects 240 million people worldwide, leads to cirrhotic liver disease, and increases risk of hepatocellular carcinoma. The HBV vaccine has decreased HBV infection and along with human papilloma virus (HPV) vaccine are the only vaccines that prevent cancer. Despite the effectiveness of HBV vaccine, some populations do not develop protective responses. The risk groups for poor response include those with immunosuppression or dialysis-dependent, end-stage renal disease.
Source: Annals of Allergy, Asthma and Immunology - March 19, 2018 Category: Allergy & Immunology Authors: Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford Tags: Review Source Type: research

Hepatitis B vaccine non-responders: possible mechanisms and solutions.
CONCLUSION: This review will provide a background on the immunology of HBV infection, the possible immunologic mechanisms to explain HBV vaccine non-responsiveness, current research aimed at improving vaccine effectiveness, and possible future approaches for providing non-responders protection from HBV. PMID: 29567355 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - March 19, 2018 Category: Allergy & Immunology Authors: Saco TV, Strauss AT, Ledford DK Tags: Ann Allergy Asthma Immunol Source Type: research

Hepatitis B vaccine nonresponders
Hepatitis B (HBV) is a viral illness that chronically infects 240 million people worldwide, leads to liver disease, and increases risk of hepatocellular carcinoma. The HBV vaccine has decreased HBV infection, and it and the human papilloma virus vaccine are the only vaccines that prevent cancer. Despite the effectiveness of the HBV vaccine, some populations do not develop protective responses. The risk groups for poor response include those with immunosuppression or dialysis-dependent, end-stage renal disease.
Source: Annals of Allergy, Asthma and Immunology - March 19, 2018 Category: Allergy & Immunology Authors: Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford Tags: Review Source Type: research

Toxic shock syndrome surveillance in UK children
Conclusions Streptococcal TSS was as frequent as staphylococcal TSS, contrasting with previous literature. Children with streptococcal TSS had a higher mortality than those with staphylococcal TSS (28% vs 0%; p<0.05). Recommended immunomodulatory agents (IVIG and clindamycin) were underused. This study highlights the need for a guideline to improve management of TSS in children.
Source: Archives of Disease in Childhood - November 13, 2014 Category: Pediatrics Authors: Adalat, S., Dawson, T., Hackett, S. J., Clark, J. E., In association with the British Paediatric Surveillance Unit Tags: Epidemiologic studies, Immunology (including allergy), Drugs: infectious diseases, Vaccination / immunisation, Neonatal and paediatric intensive care, Paediatric intensive care Original article Source Type: research